Pellegrini, C.;Husser, O.;Kim, W. K.;Holzamer, A.;Walther, T.;Rheude, T.;Mayr, N. P.;Trenkwalder, T.;Joner, M.;Michel, J.;Chaustre, F.;Kastrati, A.;Schunkert, H.;Burgdorf, C.;Hilker, M.;Mollmann, H.;Hengstenberg, C.;Trenkwalder, T.;Lahmann, A. L.;Nowicka, M.;Pellegrini, C.;Rheude, T.;Mayr, N. P.;Voss, S.;Bleiziffer, S.;Lange, R.;Joner, M.;Kasel, A. M.;Kastrati, A.;Schunkert, H.;Husser, O.;Hadamitzky, M.;Hengstenberg, C.;Mayr, N. P.;Wiesner, G.;van der Starre, P.;Hapfelmeier, A.;Goppel, G.;Kasel, A. M.;Hengstenberg, C.;Husser, O.;Schunkert, H.;Tassani-Prell, P.;Rheude, T.;Pellegrini, C.;Schmid, H.;Trenkwalder, T.;Mayr, N. P.;Joner, M.;Kasel, A. M.;Holdenrieder, S.;Nunez, J.;Sanchis, J.;Bodi, V.;Schunkert, H.;Kastrati, A.;Hengstenberg, C.;Husser, O.;Rheude, T.;Pellegrini, C.;Reinhard, W.;Trenkwalder, T.;Koenig, W.;Mayr, N. P.;Joner, M.;Nunez, J.;Holdenrieder, S.;Schunkert, H.;Kastrati, A.;Hengstenberg, C.;Husser, O.;Trenkwalder, T.;Pellegrini, C.;Holzamer, A.;Philipp, A.;Rheude, T.;Michel, J.;Reinhard, W.;Joner, M.;Kasel, A. M.;Kastrati, A.;Schunkert, H.;Endemann, D.;Debl, K.;Mayr, N. P.;Hilker, M.;Hengstenberg, C.;Husser, O.;Mayr, N. P.;Wiesner, G.;Hapfelmeier, A.;van der Starre, P.;Husser, O.;Bleiziffer, S.;Schunkert, H.;Lange, R.;Tassani-Prell, P.;Martin, K.;Rheude, T.;Pellegrini, C.;others.Predictors of Need for Permanent Pacemaker Implantation and Conduction Abnormalities With a Novel Self-expanding Transcatheter Heart Valve Incidental findings in multislice computed tomography prior to transcatheter aortic valve implantation: frequency, clinical relevance and outcome Dexmedetomidine versus propofol-opioid for sedation in transcatheter aortic valve implantation patients: a retrospective analysis of periprocedural gas exchange and hemodynamic support Comparison of Carbohydrate Antigen 125 and N-Terminal Pro-Brain Natriuretic Peptide for Risk Prediction After Transcatheter Aortic Valve Implantation Determinants of elevated carbohydrate antigen 125 in patients with severe symptomatic aortic valve stenosis referred for transcatheter aortic valve implantation Emergency extracorporeal membrane oxygenation in transcatheter aortic valve implantation: A two-center experience of incidence, outcome and temporal trends from 2010 to 2015 Periprocedural transfusion in patients undergoing transfemoral transcatheter aortic valve implantation Prognostic impact of anemia and iron-deficiency anemia in a contemporary cohort of patients undergoing transcatheter aortic valve implantation Comment to: De Waha S, Seeburger J et al. (2016): Deep sedation versus general anaesthesia in percutaneous edge-to edge mitral valve reconstruction using the MitraClip system. Clin Res Cardiol 105(6):535-43 Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With the SAPIEN 3 Balloon-Expandable Transcatheter Heart Valve Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single-Center Experience Sedation or general anesthesia for transcatheter aortic valve implantation (TAVI).Rev Esp Cardiol (Engl Ed).2018.65.6.647-657
Login
